Table 2.
Registry attribute | Frequency | ||||||
---|---|---|---|---|---|---|---|
Aims | N/37 | % | |||||
Providing subjects for clinical studies | 12 | 32 | |||||
Evaluating/improving clinical care | 9 | 24 | |||||
Describing epidemiology | 8 | 22 | |||||
Improving the understanding of natural history | 7 | 19 | |||||
Evaluating/improving health-related outcomes | 6 | 16 | |||||
Creating collaborations or clinical networks | 6 | 16 | |||||
Describing clinical characteristics of disease | 5 | 14 | |||||
Evaluating therapies or interventions | 3 | 8 | |||||
Providing evidence for management decisions | 1 | 3 | |||||
Unclear | 5 | 14 | |||||
Recruitment method | |||||||
Clinic | 34 | 92 | |||||
PAGs | 6 | 16 | |||||
Voluntarily* | 6 | 16 | |||||
Other† | 1 | 3 | |||||
Yes | No | Unclear | |||||
N/37 | % | N/37 | % | N/37 | % | ||
Informed consent | 30 | 81 | 2 | 5 | 5 | 14 | |
Core data set | 8 | 22 | 27 | 73 | 2 | 5 | |
Coding language | 9 | 24 | 24 | 65 | 4 | 11 | |
PROMS collection | 21 | 57 | 3 | 8 | 13 | 35 | |
PAG involvement | 14 | 38 | 19 | 51 | 4 | 11 | |
Governance description | 21 | 57 | 11 | 30 | 5 | 14 | |
Data security description | 28 | 76 | 6 | 16 | 3 | 8 | |
Quality monitoring | 19 | 51 | 15 | 41 | 3 | 8 | |
Maintenance description | 17 | 46 | 18 | 49 | 2 | 5 | |
Funding description | 30 | 81 | 5 | 14 | 2 | 5 |
Abbreviations: PROMS, patient-reported outcome measures; PAG, patient advocacy groups
* e.g., through social media, websites
† e.g., mandatory by law